1 authorised product containing SARS-CoV-2 spike protein recombinant, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) EU/1/21/1618/001 |
SARS-CoV-2 spike protein recombinant | Sanofi Winthrop Industrie | โ |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (โAuthorised or Transfer Pending Productsโ), licensed CC BY 4.0, refreshed daily. Regulatory information only โ not medical advice.